Arch Jr George H DDS in New Orleans, Louisiana
-
FDA proposes ending compounding flexibility for GLP-1 weight-loss drugs
The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from a key bulk-substance list used by outsourcing compounding facilities. The move follows the agency’s view that national GLP-1 supply has stabilized and that the shortage-driven flexibility is no longer needed.
-
MRI Scans: How They Work and What They Show
In summary, MRI scans are indispensable diagnostic tools.
-
5 Key Perks of Vocational Schools for Careers
Unveiling the 5 Top Benefits of Trade School Pathways
-
Exploring the Link Between Oral Health and Heart Health in Boston
Discover how Boston researchers are uncovering the vital connection between oral and heart health.
